Subject
Obstetrics and Gynaecology,Oncology
Reference28 articles.
1. Cancer statistics, 2020;Siegel;CA Cancer J. Clin.,2020
2. Synthetic lethality: general principles, utility and detection using genetic screens in human cells;Nijman;FEBS Lett.,2011
3. Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation;Kaufman;J. Clin. Oncol.,2015
4. Clinical Activity of the Poly(ADP-Ribose) Polymerase (PARP) Inhibitor Rucaparib in Patients (Pts) With High-Grade Ovarian Carcinoma (HGOC) and a BRCA Mutation (BRCAmut): Analysis of Pooled Data From Study 10 (Parts 1, 2a, & 3) and ARIEL2 (Parts 1&2);Kristeleit,2016
5. Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 part 1): an international, multicentre, open-label, phase 2 trial;Swisher;Lancet Oncol,2017
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献